BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 28811844)

  • 1. LSD1 dual function in mediating epigenetic corruption of the vitamin D signaling in prostate cancer.
    Battaglia S; Karasik E; Gillard B; Williams J; Winchester T; Moser MT; Smiraglia DJ; Foster BA
    Clin Epigenetics; 2017; 9():82. PubMed ID: 28811844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recruitment of NCOR1 to VDR target genes is enhanced in prostate cancer cells and associates with altered DNA methylation patterns.
    Doig CL; Singh PK; Dhiman VK; Thorne JL; Battaglia S; Sobolewski M; Maguire O; O'Neill LP; Turner BM; McCabe CJ; Smiraglia DJ; Campbell MJ
    Carcinogenesis; 2013 Feb; 34(2):248-56. PubMed ID: 23087083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of LSD1 (lysine-specific demethylase 1) suppresses growth and alters gene expression of human colon cancer cells in a p53- and DNMT1(DNA methyltransferase 1)-independent manner.
    Jin L; Hanigan CL; Wu Y; Wang W; Park BH; Woster PM; Casero RA
    Biochem J; 2013 Jan; 449(2):459-68. PubMed ID: 23072722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prostate cancer TMPRSS2:ERG fusion synergizes with the vitamin D receptor (VDR) to induce CYP24A1 expression-limiting VDR signaling.
    Kim JS; Roberts JM; Bingman WE; Shao L; Wang J; Ittmann MM; Weigel NL
    Endocrinology; 2014 Sep; 155(9):3262-73. PubMed ID: 24926821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation of histone H3T6 by PKCbeta(I) controls demethylation at histone H3K4.
    Metzger E; Imhof A; Patel D; Kahl P; Hoffmeyer K; Friedrichs N; Müller JM; Greschik H; Kirfel J; Ji S; Kunowska N; Beisenherz-Huss C; Günther T; Buettner R; Schüle R
    Nature; 2010 Apr; 464(7289):792-6. PubMed ID: 20228790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic regulation of vitamin D metabolism in human lung adenocarcinoma.
    Ramnath N; Nadal E; Jeon CK; Sandoval J; Colacino J; Rozek LS; Christensen PJ; Esteller M; Beer DG; Kim SH
    J Thorac Oncol; 2014 Apr; 9(4):473-82. PubMed ID: 24736069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LSD1 promotes S-phase entry and tumorigenesis via chromatin co-occupation with E2F1 and selective H3K9 demethylation.
    He Y; Zhao Y; Wang L; Bohrer LR; Pan Y; Wang L; Huang H
    Oncogene; 2018 Jan; 37(4):534-543. PubMed ID: 28991226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of lysine-specific demethylase 1 promotes androgen-independent transition of human prostate cancer LNCaP cells through activation of the AR signaling pathway and suppression of the p53 signaling pathway.
    Li X; Li T; Chen D; Zhang P; Song Y; Zhu H; Xiao Y; Xing Y
    Oncol Rep; 2016 Jan; 35(1):584-92. PubMed ID: 26534764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription.
    Metzger E; Wissmann M; Yin N; Müller JM; Schneider R; Peters AH; Günther T; Buettner R; Schüle R
    Nature; 2005 Sep; 437(7057):436-9. PubMed ID: 16079795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The combined effect of epigenetic inhibitors for LSD1 and BRD4 alters prostate cancer growth and invasion.
    Wang J; Yu Q; Qiu Z; Dai T; Wang S; Yang X; Evers BM; Wu Y
    Aging (Albany NY); 2020 Jan; 12(1):397-415. PubMed ID: 31901895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D receptor content and transcriptional activity do not fully predict antiproliferative effects of vitamin D in human prostate cancer cell lines.
    Zhuang SH; Schwartz GG; Cameron D; Burnstein KL
    Mol Cell Endocrinol; 1997 Jan; 126(1):83-90. PubMed ID: 9027366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone demethylase LSD1-mediated repression of GATA-2 is critical for erythroid differentiation.
    Guo Y; Fu X; Jin Y; Sun J; Liu Y; Huo B; Li X; Hu X
    Drug Des Devel Ther; 2015; 9():3153-62. PubMed ID: 26124638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impairment of prostate cancer cell growth by a selective and reversible lysine-specific demethylase 1 inhibitor.
    Willmann D; Lim S; Wetzel S; Metzger E; Jandausch A; Wilk W; Jung M; Forne I; Imhof A; Janzer A; Kirfel J; Waldmann H; Schüle R; Buettner R
    Int J Cancer; 2012 Dec; 131(11):2704-9. PubMed ID: 22447389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamics of 1α,25-dihydroxyvitamin D3-dependent chromatin accessibility of early vitamin D receptor target genes.
    Seuter S; Pehkonen P; Heikkinen S; Carlberg C
    Biochim Biophys Acta; 2013 Dec; 1829(12):1266-75. PubMed ID: 24185200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active vitamin D induces gene-specific hypomethylation in prostate cancer cells developing vitamin D resistance.
    Lai GR; Lee YF; Yan SJ; Ting HJ
    Am J Physiol Cell Physiol; 2020 May; 318(5):C836-C847. PubMed ID: 32159363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
    Kim S; Shevde NK; Pike JW
    J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The lysine specific demethylase-1 (LSD1/KDM1A) regulates VEGF-A expression in prostate cancer.
    Kashyap V; Ahmad S; Nilsson EM; Helczynski L; Kenna S; Persson JL; Gudas LJ; Mongan NP
    Mol Oncol; 2013 Jun; 7(3):555-66. PubMed ID: 23384557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WHSC1/NSD2 regulates immune infiltration in prostate cancer.
    Want MY; Tsuji T; Singh PK; Thorne JL; Matsuzaki J; Karasik E; Gillard B; Cortes Gomez E; Koya RC; Lugade A; Odunsi K; Battaglia S
    J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33589522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D receptor activation reduces VCaP xenograft tumor growth and counteracts ERG activity despite induction of TMPRSS2:ERG.
    Roberts JM; Martin RS; Piyarathna DB; MacKrell JG; Rocha GV; Dodge JA; Coarfa C; Krishnan V; Rowley DR; Weigel NL
    Oncotarget; 2017 Jul; 8(27):44447-44464. PubMed ID: 28591703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic Modulation of Human Podocyte Vitamin D Receptor in HIV Milieu.
    Chandel N; Ayasolla KS; Lan X; Sultana-Syed M; Chawla A; Lederman R; Vethantham V; Saleem MA; Chander PN; Malhotra A; Singhal PC
    J Mol Biol; 2015 Oct; 427(20):3201-3215. PubMed ID: 26210663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.